Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
GrayBella Capital is a pan-European venture capital firm that invests in growth-stage technology-driven companies. Founded to partner with founders in the HealthTech and DeepTech sectors, the firm focuses on supporting projects with disruptive potential. Their investment range spans from $3 million to $15 million.
The firm primarily invests in the HealthTech and DeepTech sectors. HealthTech investments include Diagnostics, Healthcare IT, Patient Monitoring, and Embedded Software, while DeepTech encompasses IoT, Cloud Computing, SaaS Platforms, AI, Machine Learning, Data Science, Quantum Computing, and Nanotechnologies.
Notable portfolio companies include Omnio Global, a banking-as-a-service platform; ATAI Life Science, focused on transforming mental health treatment; CN-Bio, a leader in organ-on-chip technology; and BC Platforms, which builds data networks for personalized medicine in life sciences.
GrayBella Capital invests in Series A, Series B, and Series C stages, focusing on growth-stage companies.
The firm typically invests between $3 million and $15 million in each portfolio company.
GrayBella Capital primarily targets the HealthTech and DeepTech sectors, supporting technology-driven innovations.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.